May 6, 2020 Roth Capital Partners Acts as Sole Placement Agent for Immunic, Inc. (Nasdaq: IMUX) in its $15 Million Registered Direct Roth Capital Partners
May 5, 2020 Roth Capital Partners Acts as Lead Placement Agent for Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) In its $20 Million Follow-On Roth Capital Partners
May 4, 2020 Roth Capital Partners Acts as Co-Manager for Arcturus Therapeutics Holdings, Inc. (NASDAQ: ARCT) in its $80.5 Million Follow-On Roth Capital Partners
Apr 24, 2020 Roth Capital Partners Acts as Sole Manager for Reed’s Inc. (Nasdaq: REED) in its $5.8 Million Follow-On Roth Capital Partners
Apr 23, 2020 Roth Capital Partners Acts as Co-Manager for Crinetics Pharmaceuticals (Nasdaq: CRNX) in its $115.1 Million Follow-On Roth Capital Partners
Apr 20, 2020 Roth Capital Partners Acts as Lead Manager for Bionano Genomics (NASDAQ: BNGO) in its $18 Million Follow-On Roth Capital Partners
Apr 16, 2020 Roth Capital Partners acts as Financial Advisor to Boardriders on its sale of Xcel to ZG Holdings Roth Capital Partners
Mar 4, 2020 Roth Capital Partners Announces the Addition of George Kelly and Matthew Koranda to its Consumer Research Group Business Wire
